Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expression

BACKGROUND: Prevention of bladder cancer recurrence is a central challenge in the management of this highly prevalent disease. The histone deacetylase inhibitor valproic acid (sodium valproate) has anti-angiogenic properties and has been shown to decrease bladder cancer growth in model systems. We h...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Byler, Timothy K, Leocadio, Dean, Shapiro, Oleg, Bratslavsky, Gennady, Stodgell, Christopher J, Wood, Ronald W, Messing, Edward M, Reeder, Jay E
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2012
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3487994/
https://ncbi.nlm.nih.gov/pubmed/22898175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2490-12-21
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak